Hyperlipidemia. Hyperlipidaemia, unspecified
Conditions
Interventions
Intervention 1: Intervention Group: grind powder of melissa officinalis at a dose of 3 gr daily (two 500mg capsules after every main course) by the oral route for two months. Intervention 2: Control
Treatment - Drugs
Placebo
Intervention Group: grind powder of melissa officinalis at a dose of 3 gr daily (two 500mg capsules after every main course) by the oral route for two months
Control Group: grind powder of corn starch at a dose of 3 gr daily (two 500mg capsuls after every main course) by the oral route for two months
Sponsors
Qazvin University of Medical Sciences
Eligibility
Sex/Gender
All
Age
25 Years to 65 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria: male and female outpatients aged 25 to 65 years; They had at least one of indices including Serum total cholesterol: 200 to 260 mg/dl; Serum low density lipoprotein: 100 to up mg/dl and Serum Triglycerides: 150 to 300 mg/dl; Body Mass Index (BMI) less than 40 Exclusion criteria: the patients who are in need of taking other antihyperlipidemic agents; patient with diabetes; coronary-vascular disease; renal; hepatic; hematological; pulmonary diseases; Uncontrolled hypertension; pregnant women; breast-feeding women; women planning pregnancy; patients using antihyperlipidemic agents; steroids; Cigarette; alcohol; they who may suffer from undesirable complications over the study including headache; vertigo; Nausea and melissa officinalis intolerance; patients Unwillingness to cooperate with this study.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Lipid profile:Total cholesterol, Triglyceride, HDL-C, LDL-C. Timepoint: Baseline and after two months. Method of measurement: Biochemical Analysis.;Liver Enzymes: ALT, AST. Timepoint: Baseline and after two months. Method of measurement: Biochemical Analysis.;Thyroid Hormones: T3, T4, TSH. Timepoint: Baseline and after two months. Method of measurement: Biochemical Analysis.;Fasting Blood Suger. Timepoint: Baseline and after two months. Method of measurement: Biochemical Analysis.;Creatinine. Timepoint: Baseline and after two months. Method of measurement: Biochemical Analysis. | — |
Secondary
| Measure | Time frame |
|---|---|
| Side Effect. Timepoint: Baseline and after two months. Method of measurement: Checklist.;Body Mass Index. Timepoint: Baseline and after two months. Method of measurement: Formula.;Pulse Rate. Timepoint: Baseline and after two months. Method of measurement: Baseline and after two months.;Blood Pressure. Timepoint: Baseline and after two months. Method of measurement: Baseline and after two months. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactDr.Mostafa Noroozi
Qazvin University of Medical Sciences
Outcome results
None listed